Cosmo NV (CMOPF)
69.50
+1.00
(+1.46%)
USD |
OTCM |
Sep 01, 16:00
Cosmo Cash from Operations (Annual) : -13.02M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -13.02M |
| December 31, 2024 | 175.92M |
| December 31, 2023 | 20.72M |
| December 31, 2022 | 32.56M |
| December 31, 2021 | 13.35M |
| December 31, 2020 | 10.74M |
| December 31, 2019 | -20.86M |
| December 31, 2018 | -8.696M |
| December 31, 2017 | -6.903M |
| December 31, 2016 | 29.21M |
| Date | Value |
|---|---|
| December 31, 2015 | -43.50M |
| December 31, 2014 | 88.14M |
| December 31, 2013 | 10.77M |
| December 31, 2012 | 29.54M |
| December 31, 2011 | 15.70M |
| December 31, 2010 | 10.30M |
| December 31, 2009 | 5.389M |
| December 31, 2008 | 18.32M |
| December 31, 2007 | -3.451M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Avadel Pharmaceuticals Plc | -- |
| Jazz Pharmaceuticals Plc | 1.356B |
| Perrigo Co. Plc | 238.50M |
| GH Research Plc | -43.55M |
| Alkermes Plc | 520.75M |